Cwm, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Cwm, LLC

$21.2 Billion
Q2 2024

A detailed history of Cwm, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Cwm, LLC holds 3,553 shares of MRVI stock, worth $30,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,553

Previous 4,445 20.07%

Holding current value

$30,697

Previous $39,000 35.9%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$6.87 - $11.34 $6,128 - $10,115	-892 Reduced 20.07%	3,553 $25,000
Q1 2024 Apr 05, 2024	SELL	$5.11 - $8.76 $1.21 Million - $2.07 Million	-236,817 Reduced 98.16%	4,445 $39,000
Q4 2023 Feb 01, 2024	SELL	$4.7 - $9.87 $41,825 - $87,833	-8,899 Reduced 3.56%	241,262 $1.58 Million
Q3 2023 Oct 11, 2023	SELL	$9.14 - $12.85 $62,508 - $87,881	-6,839 Reduced 2.66%	250,161 $2.5 Million
Q2 2023 Aug 03, 2023	BUY	$12.09 - $15.0 $691,838 - $858,360	57,224 Added 28.64%	257,000 $3.2 Million
Q1 2023 Apr 28, 2023	BUY	$12.99 - $16.48 $691,678 - $877,510	53,247 Added 36.34%	199,776 $2.8 Million
Q4 2022 Feb 01, 2023	SELL	$12.5 - $24.78 $371,862 - $737,180	-29,749 Reduced 16.88%	146,529 $2.1 Million
Q3 2022 Oct 27, 2022	SELL	$20.6 - $30.37 $154,870 - $228,321	-7,518 Reduced 4.09%	176,278 $4.5 Million
Q2 2022 Jul 28, 2022	SELL	$26.05 - $37.48 $725,857 - $1.04 Million	-27,864 Reduced 13.16%	183,796 $5.22 Million
Q1 2022 Apr 21, 2022	SELL	$24.46 - $40.92 $686,396 - $1.15 Million	-28,062 Reduced 11.71%	211,660 $7.47 Million
Q4 2021 Jan 31, 2022	BUY	$35.0 - $45.94 $8.39 Million - $11 Million	239,722 New	239,722 $10 Million

Others Institutions Holding MRVI

# of Institutions

221

Shares Held

124M

Call Options Held

176K

Put Options Held

2.2K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $1.14B
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account